Get to know our clinical trials
Ensayo para evaluar si BI 456906 ayuda a perder peso a las personas que viven con sobrepeso u obesidad que también tienen diabetes
THE AIM OF THIS STUDY IS TO FIND OUT WHETHER A NEW DRUG HELPS PEOPLE LIVING WITH OVERWEIGHT OR OBESITY AND DIABETES TO LOSE WEIGHT.
Technical Summary
- Code EudraCT: 2022-502531-18-00
- Protocol number: 1404-0041
* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.
Who can participate?
Trial to evaluate whether BI 456906 helps people living with overweight or obesity who also have diabetes to lose weight
Do you want to participate in this trial?
Request an appointment for our specialists to assess whether you qualify for this clinical trial
Do you prefer to send us your reports?
If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.